V Strant 50mg/ml Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Fulvestrant (50mg/ml)
Overview V Strant 50mg/ml Injection
Estrogen-inhibiting V Strant 50mg/ml Injection is indicated for postmenopausal women with breast cancer. Its mechanism involves estrogen modulation, thereby hindering cancer cell proliferation. Administered intramuscularly under medical guidance, dosage and frequency are individualized based on the patient's condition and determined by their physician to optimize symptom management. Treatment duration aligns with the prescribed regimen. Commonly reported adverse effects include injection site reactions, headache, nausea, vomiting, and allergic responses. Significant or persistent side effects warrant immediate physician consultation; mitigation strategies may be available. Prior to initiation, inform your doctor of any pre-existing liver or kidney disease, bleeding disorders, anticoagulant use, or concurrent medications, as interactions may impact efficacy or alter the drug's action. Disclose pregnancy, pregnancy plans, or breastfeeding status to your physician.
Primary Ingredients of V Strant 50mg/ml Injection
The information is unavailable.
Uses of V Strant 50mg/ml Injection
Malignancy of the mammary gland
Major Benefits of V Strant 50mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of V Strant 50mg/ml Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use V Strant 50mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How V Strant 50mg/ml Injection works:
Estrogen's impact on breast cancer cells is inhibited by V Strant 50mg/ml Injection. Consequently, the growth of estrogen-dependent breast cancer cells may be reduced or halted.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside V Strant 50mg/ml Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering V Strant 50mg/ml Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering V Strant 50mg/ml Injection while breastfeeding is contraindicated. Available evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Administering V Strant 50mg/ml Injection typically has no impact on driving capabilities.
KidneyCAUTION
Administering V Strant 50mg/ml Injection to individuals with severe kidney impairment requires careful consideration. Dosage modification of V Strant 50mg/ml Injection might be necessary. Physician consultation is advised. Data regarding V Strant 50mg/ml Injection use in such patients is limited. Dosage alterations are not suggested for patients exhibiting mild to moderate kidney dysfunction.
LiverCAUTION
Administering V Strant 50mg/ml Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for V Strant 50mg/ml Injection might be necessary. Physician consultation is advised.
What if you forget to take V Strant 50mg/ml Injection :
Omit a dose of V Strant 50mg/ml Injection? Seek your physician's advice.
Facts to Know About V Strant 50mg/ml Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Estrogen-based medications |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Substance blocking estrogen receptor activity |
3,018 People bought this recently